α- and β- Thalassemia StripAssays®
Genetic Mutation Detection for Thalassemia
The α- and β-Thalassemia StripAssay® kits provide easy and cost-effective solutions for the identification of the most relevant mutations in the alpha and beta globin genes, with broad mutation coverage exceeding 90% of known significant variants.
Key Features
α-Thalassemia Coverage
Detects 21 mutations in the alpha globin gene, ensuring greater than 90% coverage of known clinically significant mutations.
β-Thalassemia Kit Series
Three customized StripAssay® kits target Mediterranean, Indian/Middle Eastern, and South East Asian mutation profiles.
Reverse Hybridization Technology
Based on PCR and reverse hybridization of biotinylated products for reliable, parallel mutation detection.
Minimal Equipment Required
Requires only a thermal cycler and shaking water bath for routine clinical laboratory use.
For Research Use Only (RUO)
α- and β- Thalassemia StripAssays® is intended for research use only in the United States and is not FDA-cleared for diagnostic use.